Mwb Lifts Drägerwerk Price Target Amid Higher Margin Confidence

07:23 AM EDT, 08/31/2026 (MT Newswires) -- Mwb Research raised its price target for Drägerwerk (DRW3.F) as it lifted its margin assumptions for the German medical and safety technology company over the medium term amid higher margin confidence. "Dräger's recent performance reinforces our confidence in a structural margin improvement story, supported by higher gross margins, disciplined cost management and operating leverage. Safety remains the key earnings driver, while Medical offers further normalization potential. Even excluding c. EUR 29m of tariff reimbursements, we estimate an underlying FY26 EBIT margin of ~6.8%," analysts said in a Monday note. "Management's FY26 guidance of 2-6% currency-adjusted revenue growth and a 6-8% EBIT margin remains on track. Q3 results and the November CMD in Luebeck are the next key proof points." As such, the price target was increased to 130 euros from 114 euros, while the stock's buy rating was maintained. EBIT and EPS estimates for 2027 and 2028 were also updated, while those for 2026 remain unchanged. The research firm added that it sees further upside to its upwardly revised medium-term forecasts.